GLP-1 Drugs May Increase Rejection Risk in Lung Transplant Recipients, Study Suggests Dr. Shravani Dali3 May 2025 7:30 AM ISTA recent study presented at the 2025 International Society for Heart and Lung Transplantation (ISHLT) annual meeting suggests that glucagon-like...
Lean muscle mass loss minimized during weight loss therapy using newer incretin obesity drugs, suggests study Dr. Kamal Kant Kohli11 April 2025 9:15 AM ISTNew research to be presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14 May) shows that patients using GLP-1 or...
Anti-obesity drugs benefit kidney transplant recipients with type 2 diabetes: Study Dr. Kamal Kant Kohli15 March 2025 9:00 AM ISTKidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and...
Biocon launches Liraglutide for diabetes, obesity in UK Ruchika Sharma28 Feb 2025 8:26 PM ISTBengaluru: Biocon Limited, an innovation-led global biopharmaceutical company, has announced the launch of its GLP-1 peptide, Liraglutide, for...
Biocon, Zentiva gets Decentralized Procedure approval for generic diabetes, weight management drug in EU Ruchika Sharma24 Dec 2024 11:36 AM ISTBangalore: Biocon and its European partner, Zentiva, have received a Decentralized Procedure (DCP) approval for its complex...
GLP-1 receptor agonists also protect kidneys among patients with diabetes and obesity: Lancet Dr. Kamal Kant Kohli2 Dec 2024 8:15 AM ISTThe biggest and most comprehensive analysis of glucagon-like peptide-1 (GLP-1) receptor agonists on kidney and cardiovascular outcomes shows they have...
Bariatric surgery imore cost effective than newer weight loss drugs alone, finds study Dr. Kamal Kant Kohli7 Nov 2024 9:45 PM ISTNewer weight loss drugs are cost effective in the long term only when combined with bariatric weight loss surgery, according to a study presented at...
Popular weight-loss drugs prove more costly than metabolic and bariatric surgery within one year unravels analysis Dr. Kamal Kant Kohli9 Oct 2024 8:00 PM ISTResearchers from USF Health Morsani College of Medicine in Tampa, FL compared the cumulative cost of pharmacotherapy with GLP-1 agonists to onetime...
Liraglutide Effective in Reducing BMI in Obese Children Aged 6 to 12: SCALE Kids Trial Results Medha Baranwal18 Sept 2024 8:30 PM ISTUSA: In a recent study, liraglutide, a medication primarily used for type 2 diabetes, has demonstrated significant potential in managing obesity in...
Year-Long Weight Reduction with Semaglutide and Liraglutide: Study Reveals Impact of Dosage and Adherence Medha Baranwal16 Sept 2024 9:00 AM ISTUSA: The findings from a recent retrospective cohort study involving 3,389 patients with obesity revealed the effectiveness of semaglutide and...
Randomised Trial Finds Obesity Medication Liraglutide Safe and Effective For Children Under 12 Dr. Garima Soni12 Sept 2024 8:30 AM ISTThe obesity medication liraglutide is safe and effective in children aged 6 to <12 years, new research presented at the annual meeting of the...
Liraglutide improves myocardial perfusion, myocardial energetics and exercise capacity in Diabetics without CVD: Study Dr. Shravani Dali5 Aug 2024 9:00 AM ISTLiraglutide improves myocardial perfusion, myocardial energetics and exercise capacity in Diabetics without CVD suggests a study published in the...
